Does dexmedetomidine prevent colistin nephrotoxicity?
Dexmedetomidina impede a nefrotoxicidade da colistina?
Gamze Talih; Aliye Esmaoğ; lu; Adnan Bayram; Cevat Yazici; Kemal Deniz; Tutkun Talih
Abstract
Keywords
Resumo
Palavras-chave
References
Torres A, Ferrer M, Badia JR. Treatment guidelines and outcomes of hospital-acquired and ventilator-associated pneumonia. Clin Infect Dis. 2010;51:1114.
Alp E, Güven M, Yildiz O, Aygen B, Voss A, Doganay M. Incidence, risk factors and mortality of nosocomial pneumonia in intensive care units: a prospective study. Ann Clin Microbiol Antimicrob. 2004;3:17.
Mehndiratta MM, Nayak R, Ali S. Ventilators in ICU: a boon or burden. Ann Indian Acad Neurol. 2016;19:69-73.
Yilmaz GR, Guven T, Guner R. Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia. J Infect Dev Ctries. 2015;9:476-85.
Suzuki T, Yamaguchi H, Ogura J. Megalin contributes to kidney accumulation and nephrotoxicity of colistin. Antimicrob Agents Chemother. 2013;57:6319-24.
Ozkan G, Ulusoy S, Orem A. How does colistin-induced nephropathy develop and can it be treated?. Antimicrob Agents Chemother. 2013;57:3463-9.
Ghlissi Z, Hakim A, Sila A. Evaluation of efficacy of natural astaxanthin and vitamin E in prevention of colistin-induced nephrotoxicity in the rat model. Environ Toxicol Phar. 2014;37:960-6.
Yousef JM, Chen G, Hill PA. Melatonin attenuates colistin-induced nephrotoxicity in rats. Antimicrob Agents Chemother. 2011;55:4044-9.
Yousef JM, Chen G, Hill PA. Ascorbic acid protects against the nephrotoxicity and apoptosis caused by colistin and affects its pharmacokinetics. J Antimicrob Chemother. 2012;67:452-9.
Gertler R, Brown HC, Mitchell DH, Silvius EN. Dexmedetomidine: a novel sedative-analgesic agent. Proc (Bayl Univ Med Cent). 2001;14:13-21.
Khan ZP, Ferguson CN, Jones RM. Alpha-2 and imidazoline receptor agonists. Their pharmacology and therapeutic role. Anaesthesia. 1999;54:146-65.
Ozyilmaz E, Ebinc FA, Derici U. Could nephrotoxicity due to colistin be ameliorated with the use of N-acetylcysteine?. Intensive Care Med. 2011;37:41-146.
Keirstead ND, Wagoner MP, Bentley P. Early prediction of polymyxin-induced nephrotoxicity with next-generation urinary kidney injury biomarkers. Toxicol Sci. 2014;137:278-91.
Pettinger WA. Renal alpha 2-adrenergic receptors and hypertension. Hypertension. 1987;9:3-6.
Bayram A, Esmaoglu A, Akin A. The effects of intraoperative infusion of dexmedetomidine on early renal function after percutaneous nephrolithotomy. Acta Anaesthesiol Scand. 2011;55:539-44.
Bayram A, Ulgey A, Baykan A. The effects of dexmedetomidine on early stage renal functions in pediatric patients undergoing cardiac angiography using non-ionic contrast media: a double-blind, randomized clinical trial. Paediatr Anaesth. 2014;24:426-32.
Bhana N, Goa KL, McClellan KJ. Dexmedetomidine. Drugs. 2000;59:263-8.
Billings FT, Chen SW, Kim M. alpha2-Adrenergic agonists protect against radiocontrast-induced nephropathy in mice. Am J Physiol Renal Physiol. 2008;295.
Si YN, Bao HG, Xu L. Dexmedetomidine protects against ischemia/reperfusion injury in rat kidney. Eur Rev Med Pharmacol Sci. 2014;18:1843-51.
Yang B, El Nahas AM, Thomas GL. Caspase-3 and apoptosis in experimental chronic renal scarring. Kidney Int. 2001;60:1765-76.